Zynerba Pharma’s failed cannabidiol gel trial has upside for rival GW Pharma
August 07, 2017 at 11:01 AM EDT
GW Pharma’s Epidiolex could be the U.S.’s first cannabis-derived drug.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|